Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

Research Site, Komaki

Research Site, Seto

Research Site, Asahi

Research Site, Noda

Research Site, Touon

Research Site, Miyaodai

Research Site, Gifu

Research Site, Isesaki

Research Site, Maebashi

Research Site, Ōta

Research Site, Ōwa

Research Site, Hiroshima

Research Site, Chitose

Research Site, Kitahiroshima

Research Site, Obihiro

Research Site, Sapporo

Research Site, Tomakomai

Research Site, Morioka

Research Site, Takamatsu

Research Site, Kagoshima

Research Site, Kyoto

Research Site, Sendai

Research Site, Beppu

Research Site, Ōita

Research Site, Okayama

Research Site, Tsukubo

Research Site, Kishiwada

Research Site, Osaka

Research Site, Oskasayama

Research Site, Takatsuiki

Research Site, Koshigaya

Research Site, Minamisaitama

Research Site, Arakawa City

Research Site, Chiyoda City

Research Site, Kodaira

Research Site, Nakano-ku

Research Site, Ōta-ku

Research Site, Shinagawa-ku

Research Site, Sumida City

Research Site, tabashi City

Research Site, Toyama

Research Site, Ube

Research Site, Tochigi